-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesSep 24, 2008View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 18, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 3, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 25, 2008View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 21, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 12, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 8, 2008View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 6, 2008View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 5, 2008View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 5, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 1, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 31, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 18, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 10, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-152

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information